Status:
RECRUITING
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
Lead Sponsor:
Scripps Translational Science Institute
Conditions:
GVHD
Bone Marrow Transplant Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target ...
Detailed Description
To facilitate rapid randomization and baseline collection of patient samples in the patient's home environment, screening activities and assessment of inclusion and exclusion criteria will begin once ...
Eligibility Criteria
Inclusion
- Male or female patients aged 18 or older at the time of study informed consent.
- Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
- Patients have access to digital device capable of downloading study app
- Patients able to read study documents and able to complete informed consent within the study app
Exclusion
- Failed prior alloHSCT within the past 6 months
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06590285
Start Date
July 1 2025
End Date
October 1 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Health
San Diego, California, United States, 92037